JPMorgan analyst Robbie Marcus downgraded DexCom (NASDAQ: DXCM) from Overweight to Neutral with a price target of $75.00 (from $145.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades

DexCom (DXCM) PT Lowered to $145 at RBC CapitalJuly 26, 2024 6:34 AM Baird Downgrades DexCom (DXCM) to NeutralJuly 26, 2024 6:18 AM DexCom (DXCM) PT Lowered to $95 at UBSJuly 26, 2024 5:57 AM DexCom (DXCM) PT Lowered to $89 at Canaccord GenuityJuly 26, 2024 5:40 AM